Elevation Oncology, Inc.

NASDAQ:ELEV

0.3049 (USD) • At close June 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 000000.058000000000000000
Cost of Revenue 000.0050.0040.010.010.0090.010.010.010.0080.0050.0040.0050.0030.0060.0040000
Gross Profit 00-0.005-0.004-0.010.048-0.009-0.01-0.01-0.01-0.008-0.005-0.004-0.005-0.003-0.006-0.0040000
Gross Profit Ratio 000000.828000000000000000
Reseach & Development Expenses 6.8766.6479.3886.5516.0114.6917.4226.0297.29214.50234.3416.313.5756.2499.2983.9144.1348.4342.553.0041.488
General & Administrative Expenses 3.9653.9953.8414.4123.8583.2553.4983.8054.3464.0354.1913.8133.7933.3752.9791.1450.9520.4530.4620.4140.471
Selling & Marketing Expenses 0-3.840-0.0043.844-0.01000000000000000
SG&A 3.9653.9953.8414.4083.8483.2453.4983.8054.3464.0354.1913.8133.7933.3752.9791.1450.9520.4530.4620.4140.471
Other Expenses 3.37500000.0560.295-0.271-0.309-0.48-0.3060.1870.0930.0020.010-0.005-0.0030.0010.0120.001
Operating Expenses 14.21610.64213.22910.9599.8597.93610.929.83411.63818.53738.53120.11317.3689.62412.2775.0595.0868.8873.0123.4181.959
Operating Income -14.216-10.642-13.229-10.963-9.869-7.946-10.92-9.834-16.745-18.537-38.531-20.113-17.368-9.624-12.277-5.059-5.086-8.887-3.012-3.418-1.959
Operating Income Ratio 00000-137000000000000000
Total Other Income Expenses Net 0.0110.2150.360.513-0.8270.0560.295-0.271-0.309-0.48-0.3060.1870.0930.0020.010-0.005-0.0030.0010.0120.001
Income Before Tax -14.205-10.427-12.869-10.45-10.696-7.89-10.625-10.105-17.054-19.017-38.837-19.926-17.275-9.622-12.267-5.059-5.091-8.89-3.011-3.406-1.958
Income Before Tax Ratio 00000-136.034000000000000000
Income Tax Expense 0.0060.0090.0120.0110.0110.0090.0110.0050.0050.0250.306-0.187-0.09300000-3.012-3.418-1.959
Net Income -14.211-10.436-12.881-10.461-10.707-7.899-10.636-10.11-17.059-19.042-39.143-19.739-17.182-9.622-12.267-5.059-5.091-8.89-3.011-3.406-1.958
Net Income Ratio 00000-136.19000000000000000
EPS -0.24-0.18-0.22-0.18-0.23-0.19-0.25-0.37-0.72-0.82-1.68-0.85-0.74-0.79-0.53-4.84-0.22-0.54-0.18-0.21-0.12
EPS Diluted -0.24-0.18-0.22-0.18-0.23-0.19-0.25-0.37-0.72-0.82-1.68-0.85-0.74-0.79-0.53-4.84-0.22-0.54-0.18-0.21-0.12
EBITDA -14.216-9.464-13.224-10.959-9.859-7.936-10.911-9.824-11.628-18.537-38.523-20.108-17.364-9.619-12.274-5.053-5.082-8.872000
EBITDA Ratio 00000-136.828000000000000000